 | |
 
Threshold is a biotechnology company focused on the discovery and development of therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional drugs. Recent NewsDecember 14, 2011 December 13, 2011 November 29, 2011  View All Recent News |
|
|
|||
